Denna sida på svenska
Loading profile information...

About me

Viveca Gyberg finished her medical degree at  Karolinska Institutet in 2009, including exchangestudies at Mount Sinai School of Medicine, New York, USA. Immediately after graduating, she started her medical internship (AT) at  Karolinska University Hospital in Solna, after which she in 2011 began her five-year resident program to become a specialized family physician. She was soon awarded the position as a research resident adding two years of funded research to her specialist training which enabled her to defend her thesis on prevention of cardiovascular disease and diabetes in 2014 with Professor Lars Rydén as main supervisor.

In addition to her medical education she had spent one year (2005-2006) studying Management and International Relations at the University of St. Andrews in Scotland and six months (2002) studying democracy and human rights at the Teologiska Högskolan in Stockholm.

Viveca Gyberg has since February 2015 worked as a reoccurring TV-doctor in TV4s program Vardagspuls. She is an appreciated teacher, advisor and lecturer.

Research description

Viveca Gyberg has a strong passion for public health and prevention both on individual and societal level.

After defending her thesis in 2014 on prevention of cardiovascular disease and diabetes, Viveca Gyberg has continued as a postdoc studying prevention strategies of cardiovascular disease and diabetes in different risk groups as well as the general population. Her area of research covers policy, lifestyle, drugs, risk markers, diagnostics and medical interventions.



Accuracy of a Simplified Glucose Measurement Device--The HemoCue Glucose 201RT
Segerhag E, Gyberg V, Ioannides K, Jennings C, Rydén L, Stagmo M, et al
Diabetes technology & therapeutics 2015;17(10):755-8

Adverse Lifestyle Trends Counter Improvements in Cardiovascular Risk Factor Management in Coronary Patients
Euroaspire Investigators, Kotseva K, De Bacquer D, Jennings C, Gyberg V, De Backer G, et al
Journal of the American College of Cardiology 2015;66(14):1634-1636

Does pharmacologic treatment in patients with established coronary artery disease and diabetes fulfil guideline recommended targets? A report from the EUROASPIRE III cross-sectional study
Euroaspire Study Group, Gyberg V, Kotseva K, Dallongeville J, Backer Gd, Mellbin L, et al
European journal of preventive cardiology 2015;22(6):753-61

[Glucose impairment despite normal HbA1c or fasting plasma glucose]
Gyberg V
Lakartidningen 2015;112():-

Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology
Euroaspire Investigators, Gyberg V, De Bacquer D, De Backer G, Jennings C, Kotseva K, et al
Cardiovascular diabetology 2015;14():133-

Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV--a survey from the European Society of Cardiology
Euroaspire Iv Investigators, Gyberg V, De Bacquer D, Kotseva K, De Backer G, Schnell O, et al
European heart journal 2015;36(19):1171-7

Measuring risk online--feasibility of using FINDRISC in an online workplace survey
Gyberg V, Hasson D, Tuomilehto J, Rydén L
Primary care diabetes 2012;6(2):103-7

Policymakers' perceptions of cardiovascular health in Europe
Gyberg V, Rydén L
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2011;18(5):745-53